ReDO_DB: the repurposing drugs in oncology database (2018)

Peer-Reviewed Study · Pantziarka P, Verbaanderd C, Sukhatme V, Rica Capistrano I, Crispino S, Gyawali B, Rooman I, Van Nuffel AM, Meheus L, Sukhatme VP, Bouche G · December 6, 2018

Pantziarka P et al., 2018-12-06: The paper describing ReDO_DB, a database of 268 licensed non-cancer drugs with published anticancer evidence, built by the Anticancer Fund's ReDO project in Brussels.

Data from 268 drugs have been included in a database (ReDO_DB) developed by the ReDO project.

Pantziarka P et al., 2018-12-06: The paper describing ReDO_DB, a database of 268 licensed non-cancer drugs with published anticancer evidence, built by the Anticancer Fund's ReDO project in Brussels. F7. Study type: database description paper. Country: Belgium (The Anticancer Fund, Strombeek-Bever) with UK, US and Belgian co-authors (GlobalCures; Brigham and Women's; Emory). Funder/conflicts: not captured in the PubMed record; the authors are Anticancer Fund staff, and the Fund runs the database. This is almost certainly the database the book means when it writes 'NCI database of repurposed drugs' – it is not an NCI product, and the database is at redo-project.org/db. Two countries and two institutions are being conflated in the book's footnote. Also filed as IVB-42 (claims C9, F7).